Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Auxilium Pharmaceuticals,  : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales264395401386485570
Operating income (EBITDA)-25,210456,011,696,1153
Operating profit (EBIT)-33,285,545,1-5,1174,3150
Pre-Tax Profit (EBT)-32,985,9-96,4---
Net income-32,985,9-18,1-11713,327,5
EPS ( $)-0,691,74-0,37-2,41-0,140,55
Dividend per Share ( $)------
Yield------
Announcement Date02/23/2012
12:00pm
02/26/2013
12:00pm
02/28/2014
11:30am
---
Finances - Leverage
Auxilium Pharmaceuticals,  : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt--246464431298
Finance154157----
Operating income (EBITDA)-25,210456,011,696,1153
Leverage
(Debt/EBITDA)
--4,39x40,1x4,49x1,94x
Capital Expenditure6,648,7610,49,0911,211,8
Book Value Per Share (BVPS)1,75 $4,06 $5,07 $3,21 $2,47 $2,99 $
Cash Flow per Share0,64 $-0,05 $-0,24 $1,79 $2,89 $3,81 $
Announcement Date02/23/2012
12:00pm
02/26/2013
12:00pm
02/28/2014
11:30am
---
Balance Sheet Analysis
Auxilium Pharmaceuticals,  : Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 937 M$ -
Entreprise Value (EV) 1 400 M$ 1 368 M$
Valuation 2014e 2015e
PER (Price / EPS)
Capitalization / Revenue 2,42x 1,93x
EV / Revenue 3,62x 2,82x
EV / EBITDA 121x 14,2x
Yield (DPS / Price) - -
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) -1,32% 15,3%
operating Leverage (Delta EBIT / Delta Sales) -31,2x #
Net Margin (Net Profit / Revenue) -30,2% 2,75%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) -3,54% 43,0%
Rate of Dividend - -
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   2,35% 2,31%
Cash Flow / Sales (Taux d'autofinancement) 23,3% 30,0%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 40,1x 4,49x
Price Earning Ratio
Auxilium Pharmaceuticals,  : Price Earning Ratio
EPS & Dividend
Auxilium Pharmaceuticals,  : EPS Dividend
Dynamic quotes  
ON
| OFF